Laura Immordino

  • Citations Per Year
Learn More
BACKGROUND Multiple studies have shown that amiodarone is effective in treating atrial fibrillation (AF), but is associated with a relatively high incidence of side effects; however, due to amiodarone's long elimination half-life (20-100 days), physicians may hesitate to start other drugs until it has fully cleared. HYPOTHESIS A rapid switch from(More)
e13506 Background: This study evaluates patients for increased pulmonary arterial pressures when treated with bevacizumab, a monoclonal antibody directed against vascular endothelial growth factor (VEGF). In a small study, two patients developed severe pulmonary hypertension while on bevacizumab treatment for ovarian cancer (Liotta M et al: Pulmonary(More)
  • 1